Celldex Therapeutics
CLDX
CLDX
171 hedge funds and large institutions have $1.39B invested in Celldex Therapeutics in 2015 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 63 increasing their positions, 47 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
9% less call options, than puts
Call options by funds: $25.4M | Put options by funds: $27.8M
Holders
171
Holding in Top 10
1
Calls
$25.4M
Puts
$27.8M
Top Buyers
| 1 | +$41M | |
| 2 | +$12.7M | |
| 3 | +$11.4M | |
| 4 |
CWAM
Columbia Wanger Asset Management
Chicago,
Illinois
|
+$7.85M |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$7.05M |
Top Sellers
| 1 | -$20.6M | |
| 2 | -$18.2M | |
| 3 | -$11.3M | |
| 4 |
Millennium Management
New York
|
-$7.13M |
| 5 |
O
OppenheimerFunds
New York
|
-$4.31M |